peptibody

Related by string. * * *

Related by context. Frequent words. (Click for all words.) 73 liposomal formulation 71 proteasome inhibitor 69 humanized anti 69 targeting CD# 69 multi kinase inhibitor 69 hypoxia inducible factor 68 orally bioavailable 68 selectively inhibit 68 angiogenesis inhibitor 68 FGFR 68 immune modulator 68 TLR9 agonist 68 R sorafenib tablets 68 selective inhibition 68 Dasatinib 67 proteasome inhibitors 67 Initiates Phase II 67 Azedra 67 selective inhibitor 67 Dapagliflozin 67 peroxisome proliferator activated 67 CYC# 67 Belimumab 66 Sym# 66 HGS ETR2 66 luteinizing hormone releasing 66 partial agonist 66 investigational compounds 66 enzyme inhibitor 66 Nanobody 66 refractory chronic lymphocytic 66 histone deacetylase 66 immunomodulator 66 humanized monoclonal antibody 66 selective estrogen receptor 66 nitric oxide donating 66 Recombinant Human 66 Factor VIIa 66 VEGF receptors 66 Carfilzomib 65 mTOR inhibitor 65 vascular disrupting agent 65 Vandetanib 65 Tesetaxel 65 tyrosine kinase inhibitor 65 inhaled formulation 65 factor G CSF 65 Receives Orphan Drug Designation 65 SGLT2 65 Monoclonal Antibody 65 peptide hormone 65 FLT3 65 humanized antibody 65 synthetic peptide 65 erythropoiesis stimulating agent 65 selectively inhibits 65 Panzem R 65 small molecule inhibitor 64 enzyme inhibitors 64 PEG SN# 64 HCV protease 64 Voreloxin 64 neuroprotective properties 64 Epratuzumab 64 CD# antibody [001] 64 anti CD# monoclonal 64 CD# expressing 64 Cetrorelix 64 BZL# 64 CCX# 64 anti fibrotic 64 immunomodulating 64 drug conjugate 64 optical biosensors 64 Raltegravir 64 cyclooxygenase 64 EGF receptor 64 ALN TTR 64 AEG# 64 MKC# 64 novel orally administered 64 Drug Candidate 64 Small Molecule 64 immunomodulators 64 Daclizumab 64 MNTX 64 pegylated 63 JAK1 63 oncolytic 63 Preclinical Data 63 Amrubicin 63 Aliskiren 63 therapeutic monoclonal antibodies 63 potent inhibitor 63 GRNVAC1 63 Mipomersen 63 polymerase inhibitor 63 Vascular Endothelial Growth 63 Amgen discovers develops 63 anticancer therapies 63 anticancer agent

Back to home page